eClinical solutions enable users to integrate, manage, standardize, and analyze their clinical and operational data through advanced visualization and analytical capabilities. Gen Consulting Company estimates the global eclinical solutions market will total USD 11,659 million by 2028, an average annual growth of 13.2 percent during the forecast period, according to the latest edition of the Global eClinical Solutions Market Report.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global eclinical solutions market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the eclinical solutions industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, phase, end user, and region. The global market for eclinical solutions can be segmented by product: clinical trial operations management, electronic sourcing & clinical data management systems (CDMS), remote patient monitoring (RPM). The electronic sourcing & clinical data management systems (CDMS) segment was the largest contributor to the global eclinical solutions market in 2021. Eclinical solutions market is further segmented by phase: phase I, phase II, phase III, phase IV. Based on end user, the eclinical solutions market is segmented into: hospitals, contract research organization (CROs), academia and research institutions, pharmaceutical & biotechnology companies, others. On the basis of region, the eclinical solutions market also can be divided into: North America, Asia Pacific, Europe, Rest of the World (ROW).
By product:
– clinical trial operations management
– electronic sourcing & clinical data management systems (CDMS)
– remote patient monitoring (RPM)
By phase:
– phase I
– phase II
– phase III
– phase IV
By end user:
– hospitals
– contract research organization (CROs)
– academia and research institutions
– pharmaceutical & biotechnology companies
– others
By region:
– North America
– Asia Pacific
– Europe
– Rest of the World (ROW)
The report also provides analysis of the key companies of the industry and their detailed company profiles including ArisGlobal LLC, Clario (combination of Bioclinica and ERT), DATATRAK International, Inc., ICON plc, IQVIA Holdings Inc., Laboratory Corporation of America Holdings (Labcorp), Medidata Solutions Inc., Oracle Corporation, PAREXEL International Corporation, Veeva Systems Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
– To analyze and forecast the market size of the global eclinical solutions market.
– To classify and forecast the global eclinical solutions market based on product, phase, end user, region.
– To identify drivers and challenges for the global eclinical solutions market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global eclinical solutions market.
– To identify and analyze the profile of leading players operating in the global eclinical solutions market.
Why Choose This Report
– Gain a reliable outlook of the global eclinical solutions market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
